The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2024
Filed:
Nov. 25, 2020
Applicant:
Canopy Growth Corporation, Smiths Falls, CA;
Inventors:
Siawash Ahmar, Toronto, CA;
Krishna Kumar Gnanasekaran, Mississauga, CA;
Jeffrey Alan Omeara, Halton Hills, CA;
Assignee:
CANOPY GROWTH CORPORATION, Smith Falls, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 311/29 (2006.01); A61P 3/00 (2006.01); C07C 309/75 (2006.01); C07C 311/51 (2006.01); C07C 317/22 (2006.01); C07D 205/06 (2006.01); C07D 205/12 (2006.01); C07D 207/408 (2006.01); C07D 211/54 (2006.01); C07D 213/71 (2006.01); C07D 233/84 (2006.01); C07D 235/16 (2006.01); C07D 235/28 (2006.01); C07D 239/40 (2006.01); C07D 249/08 (2006.01); C07D 249/10 (2006.01); C07D 263/32 (2006.01); C07D 277/30 (2006.01); C07D 295/15 (2006.01); C07D 295/26 (2006.01); C07D 305/08 (2006.01); C07D 307/64 (2006.01); C07D 487/10 (2006.01);
U.S. Cl.
CPC ...
C07C 311/29 (2013.01); A61P 3/00 (2018.01); C07C 309/75 (2013.01); C07C 311/51 (2013.01); C07C 317/22 (2013.01); C07D 205/06 (2013.01); C07D 205/12 (2013.01); C07D 207/408 (2013.01); C07D 211/54 (2013.01); C07D 213/71 (2013.01); C07D 233/84 (2013.01); C07D 235/16 (2013.01); C07D 235/28 (2013.01); C07D 239/40 (2013.01); C07D 249/08 (2013.01); C07D 249/10 (2013.01); C07D 263/32 (2013.01); C07D 277/30 (2013.01); C07D 295/15 (2013.01); C07D 295/26 (2013.01); C07D 305/08 (2013.01); C07D 307/64 (2013.01); C07D 487/10 (2013.01); C07C 2601/02 (2017.05); C07C 2601/04 (2017.05); C07C 2601/14 (2017.05);
Abstract
The synthesis of a range of pentylbezene-1,3-diol compounds of formula I is disclosed. These compounds bind to cannabinoid 1 and 2 receptors (CB1 and CB2), and are thus presumed to be useful in modulating the activity of such receptors. Accordingly, the use of such synthetic cannabinoids in the treatment of various disorders mediated by CB1 and CB2 is contemplated.